US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
AU716005B2
(en)
|
1995-06-07 |
2000-02-17 |
Cook Medical Technologies Llc |
Implantable medical device
|
US5773019A
(en)
*
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
US6056734A
(en)
*
|
1997-02-07 |
2000-05-02 |
Sarcos Lc |
Method for automatic dosing of drugs
|
IN186245B
(en)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US6342250B1
(en)
|
1997-09-25 |
2002-01-29 |
Gel-Del Technologies, Inc. |
Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
|
ATE219693T1
(en)
*
|
1998-04-27 |
2002-07-15 |
Surmodics Inc |
BIOACTIVE ACTIVE COATINGS
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
US7662409B2
(en)
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US20030007991A1
(en)
*
|
1998-09-25 |
2003-01-09 |
Masters David B. |
Devices including protein matrix materials and methods of making and using thereof
|
CA2358296A1
(en)
*
|
1999-01-05 |
2000-07-13 |
Anthony P. Adamis |
Targeted transscleral controlled release drug delivery to the retina and choroid
|
WO2000045734A1
(en)
|
1999-02-02 |
2000-08-10 |
Wright Medical Technology, Inc. |
Controlled release composite
|
US6198966B1
(en)
*
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
WO2000052516A2
(en)
|
1999-03-01 |
2000-09-08 |
Boston Innovative Optics, Inc. |
System and method for increasing the depth of focus of the human eye
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
CA2383572C
(en)
|
1999-10-21 |
2007-12-11 |
Alcon Universal Ltd. |
Sub-tenon drug delivery
|
ATE283013T1
(en)
*
|
1999-10-21 |
2004-12-15 |
Alcon Inc |
MEDICATION DELIVERY DEVICE
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
US8162927B2
(en)
*
|
2000-03-21 |
2012-04-24 |
Gholam A. Peyman |
Method and apparatus for accommodating intraocular lens
|
US20070031473A1
(en)
*
|
2005-08-05 |
2007-02-08 |
Peyman Gholam A |
Drug delivery system and method
|
US6478776B1
(en)
|
2000-04-05 |
2002-11-12 |
Biocardia, Inc. |
Implant delivery catheter system and methods for its use
|
AU2001253479A1
(en)
|
2000-04-13 |
2001-10-30 |
Sts Biopolymers, Inc. |
Targeted therapeutic agent release devices and methods of making and using the same
|
US20040175410A1
(en)
*
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
US20040115268A1
(en)
*
|
2000-04-26 |
2004-06-17 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
US20040208910A1
(en)
*
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
WO2002013784A2
(en)
*
|
2000-08-14 |
2002-02-21 |
Pharmacia Corporation |
Drug delivery system with bilayer electrodes
|
ATE547080T1
(en)
*
|
2000-08-30 |
2012-03-15 |
Univ Johns Hopkins |
DEVICES FOR INTRAOCULAR DRUG DELIVERY
|
AU2002232399A1
(en)
*
|
2000-11-03 |
2002-05-15 |
Control Delivery Systems |
Improved device and method for treating conditions of a joint
|
ES2250504T3
(en)
|
2000-11-29 |
2006-04-16 |
Allergan Inc. |
PREVENTION OF REJECTION OF GRAFT IN THE EYE.
|
WO2002056863A2
(en)
*
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
DE60130928T2
(en)
*
|
2001-01-03 |
2008-07-17 |
Bausch & Lomb Inc. |
DEVICE FOR DELAYED ACTIVE INGREDIENT RELIEF WITH COATED MEDICATION CORE
|
WO2002053129A1
(en)
*
|
2001-01-03 |
2002-07-11 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with prefabricated permeable plugs
|
US6756058B2
(en)
|
2001-01-03 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
EP1847255A3
(en)
*
|
2001-01-03 |
2009-03-04 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with coated drug cores
|
JP2004520900A
(en)
*
|
2001-01-26 |
2004-07-15 |
ボシュ・アンド・ロム・インコーポレイテッド |
Improved manufacturing method of sustained release drug delivery device
|
AU2002229434A1
(en)
*
|
2001-01-29 |
2002-08-12 |
Bernard B. Fresco |
Controlled release microsphere system for administration of drug to the eye
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
US20040022853A1
(en)
*
|
2001-04-26 |
2004-02-05 |
Control Delivery Systems, Inc. |
Polymer-based, sustained release drug delivery system
|
EP2283845A1
(en)
|
2001-04-26 |
2011-02-16 |
pSivida Inc. |
Sustained release drug delivery system containing codrugs
|
JP2004536631A
(en)
|
2001-05-03 |
2004-12-09 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
Implantable drug delivery device and use thereof
|
EP1404297B1
(en)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
AU2002319606B2
(en)
*
|
2001-07-23 |
2006-09-14 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
EP1409065B1
(en)
|
2001-07-23 |
2007-01-17 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
RU2311892C2
(en)
*
|
2001-08-29 |
2007-12-10 |
КАРВАЛХО Рикардо А. П. ДЕ |
Implantable sealable system for one-way delivery of therapeutic preparations to tissues
|
IN2014DN10834A
(en)
*
|
2001-09-17 |
2015-09-04 |
Psivida Inc |
|
US20030158598A1
(en)
*
|
2001-09-17 |
2003-08-21 |
Control Delivery Systems, Inc. |
System for sustained-release delivery of anti-inflammatory agents from a coated medical device
|
US20060034929A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Brubaker Michael J |
Sustained release drug delivery devices with prefabricated permeable plugs
|
US8133501B2
(en)
|
2002-02-08 |
2012-03-13 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices for controlled drug delivery
|
US8685427B2
(en)
|
2002-07-31 |
2014-04-01 |
Boston Scientific Scimed, Inc. |
Controlled drug delivery
|
MXPA04008903A
(en)
*
|
2002-03-11 |
2004-11-26 |
Alcon Inc |
Implantable drug delivery system.
|
WO2003092468A2
(en)
*
|
2002-04-29 |
2003-11-13 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
AU2003217531A1
(en)
*
|
2002-05-02 |
2003-11-17 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US7097850B2
(en)
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
US6976584B2
(en)
|
2002-06-26 |
2005-12-20 |
Bausch & Lomb Incorporated |
Package for surgical implant
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
CN100355455C
(en)
*
|
2002-07-15 |
2007-12-19 |
爱尔康公司 |
Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
|
US8920826B2
(en)
|
2002-07-31 |
2014-12-30 |
Boston Scientific Scimed, Inc. |
Medical imaging reference devices
|
DE10238310A1
(en)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
electrode assembly
|
EP1539157B1
(en)
|
2002-09-18 |
2013-08-21 |
Trustees Of The University Of Pennsylvania |
Rapamycin for use in inhibiting or preventing choroidal neovascularization
|
US20050143363A1
(en)
*
|
2002-09-29 |
2005-06-30 |
Innorx, Inc. |
Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid of the retina; and related methods for treatment and/or prevention of retinal diseases
|
AU2003301347A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
US7354574B2
(en)
*
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
JP3814285B2
(en)
*
|
2002-12-19 |
2006-08-23 |
ファイザー・インク |
2- (1H-indazol-6-ylamino) -benzamide compounds as protein kinase inhibitors useful in the treatment of eye diseases
|
CA2510296A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Control Delivery Systems, Inc. |
Steroid compositions for intraocular use
|
US20050048099A1
(en)
*
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
US20040143327A1
(en)
*
|
2003-01-17 |
2004-07-22 |
Ku David N. |
Solid implant
|
AU2004207523A1
(en)
*
|
2003-01-24 |
2004-08-12 |
Control Delivery Systems, Inc. |
Controlled release of highly soluble agents
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
JP2006518383A
(en)
*
|
2003-02-20 |
2006-08-10 |
アルコン,インコーポレイテッド |
Glucocorticoid formulations for treating pathological ocular angiogenesis
|
PL378210A1
(en)
*
|
2003-02-20 |
2006-03-20 |
Alcon, Inc. |
Use of steroids to treat ocular disorders
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
CA2524271C
(en)
*
|
2003-05-02 |
2012-09-04 |
Surmodics, Inc. |
Controlled release bioactive agent delivery device
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
US7416546B2
(en)
*
|
2003-05-05 |
2008-08-26 |
Boston Scientific Scimed, Inc. |
Tissue patches and related delivery systems and methods
|
US8034048B2
(en)
*
|
2003-05-05 |
2011-10-11 |
Boston Scientific Scimed, Inc. |
Tissue patches and related delivery systems and methods
|
US7589107B2
(en)
*
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
US20040236343A1
(en)
*
|
2003-05-23 |
2004-11-25 |
Taylor Jon B. |
Insertion tool for ocular implant and method for using same
|
JP2007500250A
(en)
*
|
2003-06-13 |
2007-01-11 |
アルコン,インコーポレイテッド |
Nonsteroidal anti-inflammatory drug formulations for treating pathological ocular angiogenesis
|
US8715243B2
(en)
|
2003-06-16 |
2014-05-06 |
Ethicon Endo-Surgery, Inc. |
Injection port applier with downward force actuation
|
US7850660B2
(en)
|
2003-12-19 |
2010-12-14 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with simultaneous attachment mechanism and method
|
US7862546B2
(en)
*
|
2003-06-16 |
2011-01-04 |
Ethicon Endo-Surgery, Inc. |
Subcutaneous self attaching injection port with integral moveable retention members
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
US20050054586A1
(en)
*
|
2003-06-30 |
2005-03-10 |
Bartels Stephen P. |
Treatment of ophthalmic disorders
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
ZA200508654B
(en)
*
|
2003-07-10 |
2007-01-31 |
Alcon Inc |
Ophthalmic drug delivery device
|
US7083802B2
(en)
*
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
US8153591B2
(en)
|
2003-08-26 |
2012-04-10 |
Gel-Del Technologies, Inc. |
Protein biomaterials and biocoacervates and methods of making and using thereof
|
AU2004274026A1
(en)
*
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
US7083803B2
(en)
*
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US20050181018A1
(en)
*
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
US20050098470A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Davis Michael J. |
Kit for administration of a drug
|
ATE460901T1
(en)
*
|
2003-11-13 |
2010-04-15 |
Psivida Inc |
SUSTAINED RELEASE INJECTABLE IMPLANT HAVING A BIOERODIBLE MATRIX CORE AND A BIOERODIBLE SKIN
|
US20050130906A1
(en)
*
|
2003-11-20 |
2005-06-16 |
Matier William L. |
Amelioration of macular degeneration and other ophthalmic diseases
|
US8529939B2
(en)
*
|
2003-12-08 |
2013-09-10 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
US8162897B2
(en)
|
2003-12-19 |
2012-04-24 |
Ethicon Endo-Surgery, Inc. |
Audible and tactile feedback
|
US20050137538A1
(en)
|
2003-12-22 |
2005-06-23 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20050158365A1
(en)
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
US7976858B2
(en)
|
2004-01-13 |
2011-07-12 |
The Hospital For Special Surgery |
Drug delivery to a joint
|
US7544176B2
(en)
|
2005-06-21 |
2009-06-09 |
Becton, Dickinson And Company |
Glaucoma implant having MEMS flow module with flexing diaphragm for pressure regulation
|
US7364564B2
(en)
|
2004-03-02 |
2008-04-29 |
Becton, Dickinson And Company |
Implant having MEMS flow module with movable, flow-controlling baffle
|
US20050194303A1
(en)
*
|
2004-03-02 |
2005-09-08 |
Sniegowski Jeffry J. |
MEMS flow module with filtration and pressure regulation capabilities
|
US7384550B2
(en)
|
2004-02-24 |
2008-06-10 |
Becton, Dickinson And Company |
Glaucoma implant having MEMS filter module
|
WO2005099787A1
(en)
|
2004-04-06 |
2005-10-27 |
Surmodics, Inc. |
Coating compositions for bioactive agents
|
US20060018949A1
(en)
*
|
2004-04-07 |
2006-01-26 |
Bausch & Lomb Incorporated |
Injectable biodegradable drug delivery system
|
US20050232972A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
AU2005240078A1
(en)
*
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing
|
US20060024350A1
(en)
*
|
2004-06-24 |
2006-02-02 |
Varner Signe E |
Biodegradable ocular devices, methods and systems
|
WO2006004795A2
(en)
|
2004-06-25 |
2006-01-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
AU2005269988B2
(en)
*
|
2004-07-02 |
2012-02-02 |
Mati Therapeutics Inc. |
Treatment medium delivery device and methods for delivery
|
US20060110428A1
(en)
*
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
US20060045865A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
WO2006026504A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Mucoadhesive oral formulations of high permeability, high solubility drugs
|
US20060047250A1
(en)
*
|
2004-08-30 |
2006-03-02 |
Hickingbotham Dyson W |
Fluid delivery device
|
US7402156B2
(en)
*
|
2004-09-01 |
2008-07-22 |
Alcon, Inc. |
Counter pressure device for ophthalmic drug delivery
|
US20060046961A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
US20060046960A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
CA2581126A1
(en)
|
2004-09-24 |
2006-04-06 |
Rfe Pharma Llc |
Carboxy-amido-triazoles for the localized treatment of ocular diseases
|
US20160106717A1
(en)
|
2004-09-24 |
2016-04-21 |
Gen Pharma Holdings LLC |
Cai-based systems and methods for the localized treatment of uveitis
|
US20060067978A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly(vinyl alcohol) drug delivery devices
|
US20060068012A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
|
US20080275133A1
(en)
*
|
2004-09-30 |
2008-11-06 |
University Of Calfornia-San Francisco |
Local Administration of Retinoids to Treat Deficiencies in Dark Adaptation
|
WO2006039459A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
WO2006039333A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Ophthalmic drug release device for multiple drug release
|
US20060078592A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Bausch & Lomb Incorporated |
Drug delivery systems
|
US7226435B2
(en)
*
|
2004-10-14 |
2007-06-05 |
Alcon, Inc. |
Drug delivery device
|
US20060107555A1
(en)
*
|
2004-11-09 |
2006-05-25 |
Curtis Marc D |
Universal snow plow adapter
|
US20060116682A1
(en)
*
|
2004-11-18 |
2006-06-01 |
Longo Marc N |
Surgical implant and methods of making and using the same
|
WO2006057859A1
(en)
*
|
2004-11-24 |
2006-06-01 |
Therakine Corporation |
An implant for intraocular drug delivery
|
US20070276481A1
(en)
*
|
2004-12-08 |
2007-11-29 |
Renner Steven B |
Drug delivery device
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
WO2006068898A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Bausch & Lomb Incorporated |
Reusable drug delivery device
|
US20060163111A1
(en)
*
|
2004-12-23 |
2006-07-27 |
Baril Daniel J |
Device holder apparatus
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
KR101387456B1
(en)
|
2005-02-09 |
2014-04-21 |
산텐 세이야꾸 가부시키가이샤 |
Liquid formulations for treatment of diseases or conditions
|
WO2006110487A1
(en)
*
|
2005-04-08 |
2006-10-19 |
Surmodics, Inc. |
Sustained release implants for subretinal delivery
|
WO2006122414A1
(en)
*
|
2005-05-17 |
2006-11-23 |
Matregen Corp. |
Depot for sustained and controlled delivery of methotrexate
|
WO2006127592A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Othera Pharmaceuticals, Inc. |
Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
|
US20070026047A1
(en)
*
|
2005-06-21 |
2007-02-01 |
Li-Chun Tsou |
Thermal effect on crystalinity for drug delivery devices
|
US7651483B2
(en)
|
2005-06-24 |
2010-01-26 |
Ethicon Endo-Surgery, Inc. |
Injection port
|
US7918844B2
(en)
|
2005-06-24 |
2011-04-05 |
Ethicon Endo-Surgery, Inc. |
Applier for implantable medical device
|
US20060292202A1
(en)
*
|
2005-06-27 |
2006-12-28 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20070014760A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
WO2007011880A2
(en)
|
2005-07-18 |
2007-01-25 |
Minu, L.L.C. |
Enhanced ocular neuroprotection/neurostimulation
|
CN101600475A
(en)
|
2005-07-27 |
2009-12-09 |
佛罗里达大学研究基金会有限公司 |
Revise the miniaturization compound and the use thereof of protein false folding
|
US20070060887A1
(en)
*
|
2005-08-22 |
2007-03-15 |
Marsh David A |
Ophthalmic injector
|
US8067189B2
(en)
*
|
2005-09-01 |
2011-11-29 |
Bristol-Myers Squibb Company |
Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IV
|
WO2007047626A1
(en)
*
|
2005-10-14 |
2007-04-26 |
Alcon, Inc. |
Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis
|
JP2009514969A
(en)
|
2005-11-09 |
2009-04-09 |
コンビナトアールエックス インコーポレーティッド |
Methods, compositions, and kits for treating medical conditions
|
MX2008006379A
(en)
|
2005-11-29 |
2009-03-03 |
Smithkline Beecham Corp |
Treatment method.
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
EP2001438A2
(en)
|
2006-02-09 |
2008-12-17 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
DK2001466T3
(en)
|
2006-03-23 |
2016-02-29 |
Santen Pharmaceutical Co Ltd |
LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES
|
KR20110038144A
(en)
|
2006-03-31 |
2011-04-13 |
큐엘티 플러그 딜리버리, 인코포레이티드 |
Drug delivery methods, structures, and compositions for nasolacrimal system
|
US20070270750A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Alcon, Inc. |
Drug delivery device
|
US7811252B2
(en)
*
|
2006-05-17 |
2010-10-12 |
Alcon Research, Ltd. |
Dosage control device
|
US7674243B2
(en)
*
|
2006-05-17 |
2010-03-09 |
Alcon Inc. |
Ophthalmic injection device using piezoelectric array
|
US7815603B2
(en)
*
|
2006-05-17 |
2010-10-19 |
Alcon Research, Ltd. |
Ophthalmic injection method
|
US20070268340A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Ophthalmic Injection System and Method Using Piezoelectric Array
|
US7862540B2
(en)
*
|
2006-05-17 |
2011-01-04 |
Alcon Research, Ltd. |
Ophthalmic injection device using shape memory alloy
|
US7887521B2
(en)
*
|
2006-05-17 |
2011-02-15 |
Alcon Research, Ltd. |
Ophthalmic injection system
|
US20070270768A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Mechanical Linkage Mechanism For Ophthalmic Injection Device
|
JP4827626B2
(en)
*
|
2006-06-14 |
2011-11-30 |
キヤノン株式会社 |
CONTROLLED DEVICE, REMOTE CONTROL SYSTEM, REMOTE CONTROL SYSTEM CONTROL METHOD, PROGRAM
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
JP5241714B2
(en)
|
2006-07-07 |
2013-07-17 |
プロテウス デジタル ヘルス, インコーポレイテッド |
Smart parenteral delivery system
|
MX2009001334A
(en)
|
2006-08-07 |
2009-02-13 |
Bausch & Lomb |
Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof.
|
US9744137B2
(en)
*
|
2006-08-31 |
2017-08-29 |
Supernus Pharmaceuticals, Inc. |
Topiramate compositions and methods of enhancing its bioavailability
|
WO2008027796A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Bausch & Lomb Incorporated |
Compositions and methods for treating or preventing glaucoma or progression thereof
|
US20110104159A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
|
ES2361585T3
(en)
*
|
2006-09-11 |
2011-06-20 |
BAUSCH & LOMB INCORPORATED |
COMPOSITIONS AND METHODS TO TREAT, CONTROL, REDUCE, IMPROVE OR PREVENT ALLERGY.
|
US20110105559A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
|
US20080097379A1
(en)
*
|
2006-09-26 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection method
|
US20080125712A1
(en)
*
|
2006-09-26 |
2008-05-29 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection system
|
US20080097390A1
(en)
*
|
2006-09-27 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Spring actuated delivery system
|
KR20090067218A
(en)
*
|
2006-10-16 |
2009-06-24 |
알콘 리서치, 리미티드 |
Method of operating ophthalmic hand piece with disposable end
|
US9022970B2
(en)
*
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
EP2063829B1
(en)
*
|
2006-10-16 |
2010-12-08 |
Alcon Research, Ltd. |
Universal rechargeable limited reuse assembly for ophthalmic hand piece
|
US20080281292A1
(en)
*
|
2006-10-16 |
2008-11-13 |
Hickingbotham Dyson W |
Retractable Injection Port
|
AU2007319141B2
(en)
|
2006-11-17 |
2013-01-10 |
Supernus Pharmaceuticals Inc. |
Sustained-release formulations of topiramate
|
US20080140024A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Yoseph Yaacobi |
Drug delivery device
|
US20080145405A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Kunzler Jay F |
Drug delivery devices
|
UY30883A1
(en)
|
2007-01-31 |
2008-05-31 |
Alcon Res |
PUNCTURAL PLUGS AND METHODS OF RELEASE OF THERAPEUTIC AGENTS
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
US20080299176A1
(en)
*
|
2007-05-30 |
2008-12-04 |
Yu-Chin Lai |
Drug delivery device comprising crosslinked polyurethane-siloxane-containing copolymers
|
US20090018512A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Ophthalmic Injector
|
US20090018548A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge
|
US7740619B2
(en)
*
|
2007-08-01 |
2010-06-22 |
Alcon Research, Ltd. |
Spring driven ophthalmic injection device with safety actuator lockout feature
|
US20090036842A1
(en)
*
|
2007-08-03 |
2009-02-05 |
Raffi Pinedjian |
Consumable Activation Lever For Injection Device
|
US8092541B2
(en)
*
|
2007-08-03 |
2012-01-10 |
Warsaw Orthopedic, Inc. |
Method of using an anti-growth matrix as a barrier for cell attachment and osteo-inductive factors
|
US7629768B2
(en)
*
|
2007-08-03 |
2009-12-08 |
Alcon Research, Ltd. |
Easy cleaning C-shaped charging base
|
US20090042936A1
(en)
*
|
2007-08-10 |
2009-02-12 |
Ward Keith W |
Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
|
US20090062922A1
(en)
*
|
2007-09-05 |
2009-03-05 |
Mckay William F |
Method and apparatus for delivering treatment to a joint
|
US7910123B2
(en)
*
|
2007-09-05 |
2011-03-22 |
Warsaw Orthopedic |
Methods of treating a trauma or disorder of the knee joint by local administration and sustained-delivery of a biological agent
|
KR101996336B1
(en)
*
|
2007-09-07 |
2019-07-04 |
마티 테라퓨틱스 인코포레이티드 |
Drug cores for sustained release of therapeutic agents
|
CA2698508C
(en)
|
2007-09-07 |
2017-06-06 |
Alan R. Rapacki |
Lacrimal implants and related methods
|
EP2205192A2
(en)
*
|
2007-09-07 |
2010-07-14 |
QLT Plug Delivery, Inc. |
Insertion and extraction tools for lacrimal implants
|
CA2698580C
(en)
*
|
2007-09-07 |
2016-10-11 |
Qlt Plug Delivery, Inc. |
Lacrimal implant detection
|
US20090087443A1
(en)
|
2007-09-27 |
2009-04-02 |
Bartels Stephen P |
Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
|
MX2010003364A
(en)
|
2007-10-08 |
2010-07-06 |
Lux Biosciences Inc |
Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors.
|
US9125979B2
(en)
|
2007-10-25 |
2015-09-08 |
Proteus Digital Health, Inc. |
Fluid transfer port information system
|
GB0722484D0
(en)
*
|
2007-11-15 |
2007-12-27 |
Ucl Business Plc |
Solid compositions
|
EP2237770A4
(en)
*
|
2007-12-26 |
2011-11-09 |
Gel Del Technologies Inc |
Biocompatible protein particles, particle devices and methods thereof
|
WO2009097468A2
(en)
|
2008-01-29 |
2009-08-06 |
Kliman Gilbert H |
Drug delivery devices, kits and methods therefor
|
CN102014816B
(en)
*
|
2008-02-18 |
2015-04-15 |
马缇医疗股份有限公司 |
Lacrimal implants and related methods
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
US8940315B2
(en)
|
2008-04-18 |
2015-01-27 |
Medtronic, Inc. |
Benzodiazepine formulation in a polyorthoester carrier
|
US8956642B2
(en)
|
2008-04-18 |
2015-02-17 |
Medtronic, Inc. |
Bupivacaine formulation in a polyorthoester carrier
|
US20090269390A1
(en)
*
|
2008-04-25 |
2009-10-29 |
Medtronic, Inc. |
Medical devices, polymers, compositions, and methods for delivering a haloacetate
|
CA2722002C
(en)
|
2008-04-30 |
2018-06-19 |
Qlt Plug Delivery, Inc. |
Composite lacrimal insert and related methods
|
CN105251007A
(en)
*
|
2008-05-09 |
2016-01-20 |
马缇医疗股份有限公司 |
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
WO2010057177A2
(en)
|
2008-11-17 |
2010-05-20 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
US20100158980A1
(en)
|
2008-12-18 |
2010-06-24 |
Casey Kopczynski |
Drug delivery devices for delivery of therapeutic agents
|
PL2391419T3
(en)
|
2009-01-29 |
2019-12-31 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
EP2396070A4
(en)
|
2009-02-12 |
2012-09-19 |
Incept Llc |
Drug delivery through hydrogel plugs
|
WO2010093945A2
(en)
|
2009-02-13 |
2010-08-19 |
Glaukos Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
CN105997339B
(en)
*
|
2009-02-23 |
2018-09-04 |
马缇医疗股份有限公司 |
Lacrimal implants
|
US20110077270A1
(en)
*
|
2009-04-21 |
2011-03-31 |
Pfeffer Bruce A |
Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
|
US8372036B2
(en)
|
2009-05-06 |
2013-02-12 |
Alcon Research, Ltd. |
Multi-layer heat assembly for a drug delivery device
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
WO2010135369A1
(en)
*
|
2009-05-18 |
2010-11-25 |
Dose Medical Corporation |
Drug eluting ocular implant
|
ES2921527T3
(en)
|
2009-06-03 |
2022-08-29 |
Forsight Vision5 Inc |
Anterior segment drug delivery
|
AU2010259184B2
(en)
*
|
2009-06-09 |
2015-08-13 |
Aurinia Pharmaceuticals Inc. |
Topical drug delivery systems for ophthalmic use
|
IN2012DN00352A
(en)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
US20110238036A1
(en)
*
|
2009-12-23 |
2011-09-29 |
Psivida Us, Inc. |
Sustained release delivery devices
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
US20110189174A1
(en)
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
JP5841951B2
(en)
|
2010-02-01 |
2016-01-13 |
プロテウス デジタル ヘルス, インコーポレイテッド |
Data collection system
|
CN102905612A
(en)
|
2010-02-01 |
2013-01-30 |
普罗秋斯数字健康公司 |
Two-wrist data gathering system
|
NZ629829A
(en)
|
2010-04-30 |
2015-11-27 |
Alexion Pharma Inc |
Anti-c5a antibodies and methods for using the antibodies
|
WO2011146483A1
(en)
|
2010-05-17 |
2011-11-24 |
Aerie Pharmaceuticals, Inc. |
Drug delivery devices for delivery of ocular therapeutic agents
|
SI2600812T1
(en)
|
2010-08-05 |
2021-12-31 |
ForSight Vision4, Inc., |
Apparatus to treat an eye
|
EP3861969A1
(en)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injector apparatus for drug delivery
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
CA2818612C
(en)
|
2010-11-19 |
2020-12-29 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
US9415193B2
(en)
|
2011-03-04 |
2016-08-16 |
W. L. Gore & Associates, Inc. |
Eluting medical devices
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
US20120316199A1
(en)
|
2011-06-07 |
2012-12-13 |
Ward Keith W |
Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
|
EA032666B1
(en)
|
2011-06-14 |
2019-06-28 |
Бикам Фармасьютикалз, Инк. |
Opsin-binding ligands and methods of use thereof
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
CA2846384C
(en)
|
2011-08-29 |
2020-12-15 |
Qlt Inc. |
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
WO2013040238A2
(en)
*
|
2011-09-13 |
2013-03-21 |
Vista Scientific Llc |
Sustained release ocular drug delivery devices and methods of manufacture
|
RU2740680C2
(en)
|
2011-09-14 |
2021-01-19 |
Форсайт Вижн5, Инк. |
Eye inserter device and methods
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
SI2755600T1
(en)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus
|
EP2768307B1
(en)
|
2011-10-19 |
2020-03-18 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
US9353063B2
(en)
|
2011-11-30 |
2016-05-31 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
CA2862746A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
US9545303B2
(en)
|
2011-12-02 |
2017-01-17 |
Acufocus, Inc. |
Ocular mask having selective spectral transmission
|
US9205150B2
(en)
|
2011-12-05 |
2015-12-08 |
Incept, Llc |
Medical organogel processes and compositions
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
MX351261B
(en)
|
2012-06-01 |
2017-10-06 |
Surmodics Inc |
Apparatus and method for coating balloon catheters.
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
US10173038B2
(en)
|
2012-09-05 |
2019-01-08 |
W. L. Gore & Associates, Inc. |
Retractable sheath devices, systems, and methods
|
US20140100530A1
(en)
|
2012-10-05 |
2014-04-10 |
Miguel A. Linares |
Attachable uterine device with integrated and time release medicinal administering component and insertion tool for implanting such a device
|
PT2911623T
(en)
|
2012-10-26 |
2019-11-21 |
Forsight Vision5 Inc |
Ophthalmic system for sustained release of drug to eye
|
EP2968613B1
(en)
|
2013-03-11 |
2019-09-11 |
University of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for occular inflammation
|
US9204962B2
(en)
|
2013-03-13 |
2015-12-08 |
Acufocus, Inc. |
In situ adjustable optical mask
|
AU2014236455B2
(en)
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US9427922B2
(en)
|
2013-03-14 |
2016-08-30 |
Acufocus, Inc. |
Process for manufacturing an intraocular lens with an embedded mask
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
EP4302736A3
(en)
|
2013-03-28 |
2024-04-03 |
ForSight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
US10098836B2
(en)
|
2013-05-02 |
2018-10-16 |
Retina Foundation Of The Southwest |
Method for forming a molded two-layer ocular implant
|
WO2015071427A1
(en)
*
|
2013-11-14 |
2015-05-21 |
Eyed Pharma |
Eye device
|
NZ711451A
(en)
|
2014-03-07 |
2016-05-27 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
AU2015266850B2
(en)
|
2014-05-29 |
2019-12-05 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
US10258503B2
(en)
|
2014-07-15 |
2019-04-16 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
US10080877B2
(en)
|
2014-07-25 |
2018-09-25 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a drug cartridge
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
MY182793A
(en)
|
2014-08-08 |
2021-02-05 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
US9814673B2
(en)
*
|
2014-08-12 |
2017-11-14 |
Imprimis Pharmaceuticals, Inc. |
Intraocular lens comprising pharmaceutical compositions and methods for fabricating thereof
|
US10507101B2
(en)
|
2014-10-13 |
2019-12-17 |
W. L. Gore & Associates, Inc. |
Valved conduit
|
US10500091B2
(en)
|
2014-11-10 |
2019-12-10 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|
EP3283004A4
(en)
|
2015-04-13 |
2018-12-05 |
Forsight Vision5, Inc. |
Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
|
US10206978B2
(en)
|
2015-06-08 |
2019-02-19 |
Retinal Solutions Llc |
Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema
|
US10669321B2
(en)
|
2015-06-08 |
2020-06-02 |
Retinal Solutions Llc |
Retinal capillary regeneration with synthetic norrin protein
|
US10202429B2
(en)
|
2015-06-08 |
2019-02-12 |
Retinal Solutions Llc |
Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
US10182939B2
(en)
|
2015-09-16 |
2019-01-22 |
Novartis Ag |
Hydraulic injector and methods for intra-ocular lens insertion
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
CN108430405B
(en)
|
2015-11-20 |
2021-04-13 |
弗赛特影像4股份有限公司 |
Porous structures for sustained release drug delivery devices
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
US11617680B2
(en)
|
2016-04-05 |
2023-04-04 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
AU2017252294B2
(en)
|
2016-04-20 |
2021-12-02 |
Dose Medical Corporation |
Bioresorbable ocular drug delivery device
|
USD802756S1
(en)
|
2016-06-23 |
2017-11-14 |
Warsaw Orthopedic, Inc. |
Drug pellet cartridge
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
US11523940B2
(en)
|
2017-03-17 |
2022-12-13 |
W. L. Gore & Associates, Inc. |
Delivery aids for glaucoma shunts
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
EA202090247A1
(en)
|
2017-07-14 |
2020-05-12 |
Цитомкс Терапьютикс, Инк. |
ANTIBODIES AGAINST CD166 AND THEIR APPLICATION
|
US11365241B2
(en)
|
2017-07-27 |
2022-06-21 |
Alexion Pharmaceuticals, Inc. |
High concentration anti-C5 antibody formulations
|
US10744313B2
(en)
*
|
2017-07-27 |
2020-08-18 |
University Of Utah Research Foundation |
Therapeutic delivery device
|
WO2019103906A1
(en)
|
2017-11-21 |
2019-05-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
SG11202005949UA
(en)
|
2018-05-24 |
2020-07-29 |
Celanese Eva Performance Polymers Corp |
Implantable device for sustained release of a macromolecular drug compound
|
US11690807B2
(en)
|
2018-05-24 |
2023-07-04 |
Celanese Eva Performance Polymers Llc |
Implantable device for sustained release of a macromolecular drug compound
|
WO2020112816A1
(en)
|
2018-11-29 |
2020-06-04 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
US11678983B2
(en)
|
2018-12-12 |
2023-06-20 |
W. L. Gore & Associates, Inc. |
Implantable component with socket
|
BR112021012172A2
(en)
|
2018-12-12 |
2021-08-31 |
Kite Pharma, Inc. |
CHIMERIC AND T-CELL ANTIGEN RECEPTORS AND METHODS OF USE
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
WO2021217024A1
(en)
|
2020-04-24 |
2021-10-28 |
Millennium Pharmaceuticals, Inc. |
Anti-cd19 antibodies and uses thereof
|
CN112569457B
(en)
*
|
2020-12-10 |
2024-02-13 |
北京大学第三医院(北京大学第三临床医学院) |
Continuous administration cyst tube system
|
CN117425673A
(en)
|
2021-04-09 |
2024-01-19 |
武田药品工业株式会社 |
Antibodies targeting complement factor D and uses thereof
|
KR20240004286A
(en)
|
2021-04-26 |
2024-01-11 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
Anti-Clec12A antibodies and uses thereof
|
EP4330283A1
(en)
|
2021-04-26 |
2024-03-06 |
Millennium Pharmaceuticals, Inc. |
Anti-adgre2 antibodies and uses thereof
|
WO2023031277A1
(en)
|
2021-08-31 |
2023-03-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the treatment of ocular rosacea
|
AU2022372894A1
(en)
|
2021-10-20 |
2024-04-18 |
Takeda Pharmaceutical Company Limited |
Compositions targeting bcma and methods of use thereof
|